Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10014977HBVENSG00000130287.14protein_codingNCANNoNo1463O14594
TVIS10014978HBVENSG00000130287.14protein_codingNCANNoNo1463O14594
TVIS10028220HBVENSG00000130287.14protein_codingNCANNoNo1463O14594
TVIS10028221HBVENSG00000130287.14protein_codingNCANNoNo1463O14594
TVIS10028222HBVENSG00000130287.14protein_codingNCANNoNo1463O14594
TVIS20007055HPVENSG00000130287.14protein_codingNCANNoNo1463O14594
TCGA Plot Options
Drug Information
GeneNCAN
DrugBank IDDB08818
Drug NameHyaluronic acid
Target IDBE0004512
UniProt IDO14594
Regulation Typebinder
PubMed IDs7595522; 11486035
CitationsMeyer-Puttlitz B, Milev P, Junker E, Zimmer I, Margolis RU, Margolis RK: Chondroitin sulfate and chondroitin/keratan sulfate proteoglycans of nervous tissue: developmental changes of neurocan and phosphacan. J Neurochem. 1995 Nov;65(5):2327-37. doi: 10.1046/j.1471-4159.1995.65052327.x.@@Zhou XH, Brakebusch C, Matthies H, Oohashi T, Hirsch E, Moser M, Krug M, Seidenbecher CI, Boeckers TM, Rauch U, Buettner R, Gundelfinger ED, Fassler R: Neurocan is dispensable for brain development. Mol Cell Biol. 2001 Sep;21(17):5970-8. doi: 10.1128/mcb.21.17.5970-5978.2001.
GroupsApproved; Vet_approved
Direct ClassificationAcylaminosugars
SMILESCC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@@H]1O[C@@H]([C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)C(O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)[C@H]2NC(C)=O)[C@H](O)[C@H]1O)C(O)=O
Pathways
PharmGKBPA165958431
ChEMBL